• Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Recommendation of "Moderate Buy" by Analysts

    Источник: Buzz FX / 06 фев 2025 02:26:10   America/Chicago


    Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat February 6, 2025 Share Link copied to clipboard. Allogene Therapeutics, Inc. ( NASDAQ:ALLO - Get Free Report ) has be
    Read more...
Опубликовать